We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > out-licensing

News List

ISSAR Pharma announces out-licensing of its peptide-based NCEs expresspharma
April 21, 2021
ISSAR has several patents for peptide molecules lined up in their development pipeline targeting therapeutic areas such as oncology, dermatology, gastroenterology and diseases of bones and joints.
JW Pharmaceutical signs global out-licensing agreement for their novel atopic dermatitis drug candidate, JW1601, with LEO Pharma, a global leader in medical dermatology pharmafocusasia
November 27, 2018
W Pharmaceutical and LEO Pharma A/S announced today, that they have signed a global licensing agreement for JWP’s novel atopic dermatitis drug candidate....
Dr. Reddy's Laboratories Announces the Out-Licensing of DFD-06 to Encore Dermatology pharmaceutical-technology
August 23, 2017
Dr. Reddy’s Laboratories has out-licensed the future development, manufacturing, and commercialization rights of DFD-06, a topical high potency steroid, to Encore Dermatology. The drug is intended to be used for treatment of moderate to severe plaque psor